Redcare Pharmacy

Redcare Pharmacy shares rose about nine percent on Wednesday to roughly €74.15, putting the stock at the top of the SDAX. Berenberg raised its price target from €94 to €102 and MPCM increased theirs from €116 to €120; both firms maintained their buy recommendations. Analysts see prescription-drug sales and improved shopping experiences as drivers, and the chart remains positive above key moving averages following the recent forecast upgrade. » More on finanzen.net

Shares of Redcare Pharmacy gained around nine percent to €74.15 and led the SDax after Berenberg and MPCM raised their price targets and reaffirmed buy recommendations. MPCM lifted its target to €120 (previously €116), Berenberg to €102 (previously €94). Analysts cite the prescription-drug business and improved shopping experiences as drivers, leading to more frequent prescription fills and higher basket values. » More on finanzen.net

Analysts at Berenberg have raised the price target for Redcare Pharmacy from €94 to €102 and confirm the "Buy" rating. The reason is improved shopping experiences for prescription medicines, which lead to more frequent prescription redemptions and higher basket values. Management has raised its sales forecast for the current year to +16–18%; Rx sales are expected to be €730–760 million. Technically, a sustained breakout above the resistance around €70 did not occur, so investors remain cautious. » More on deraktionaer.de